Keith R. McCain profile photo

Keith R. McCain

Associate Professor

Last publication 2023 Last refreshed 2026-04-25

faculty

Poision Control, College of Pharmacy

10 h-index 12 pubs 500 cited

Biography and Research Information

OverviewAI-generated summary

Keith R. McCain's research focuses on the metabolism and toxicology of novel psychoactive substances, particularly synthetic cannabinoids. His work investigates the enzymes involved in the oxidative metabolism of these compounds, with a recent publication identifying the specific cytochrome P450 enzymes responsible for the metabolism of the synthetic cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019). McCain has a scholarly record of 12 publications, with a total of 499 citations and an h-index of 10. He collaborates with other researchers, including William E. Fantegrossi at the University of Arkansas for Medical Sciences, with whom he shares one publication. McCain's work contributes to understanding the pharmacokinetic and pharmacodynamic profiles of substances relevant to substance-related disorders.

Metrics

  • h-index: 10
  • Publications: 12
  • Citations: 500

Selected Publications

  • Identification of Cytochrome P450 Enzymes Responsible for Oxidative Metabolism of Synthetic Cannabinoid (1-Hexyl-1H-Indol-3-yl)-1-naphthalenyl-methanone (JWH-019) (2023)
    1 citation DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

  • Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH/NIDA Co-Investigator
  • Synthetic Cannabinoid Toxicity: Role of Biotransformation NIH Co-Investigator

Collaboration Network

4 Collaborators 2 Institutions 1 Country

Top Collaborators

View profile →

Similar Researchers

Based on overlapping research topics